Ikena Oncology, Inc.IKNANASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank29
Studio
Year-over-Year Change

Return on equity

Percentile
P29
Within normal range
vs 5Y Ago
-0.8x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025-34.06%-17.3%
2024-29.04%+27.7%
2023-40.16%+14.2%
2022-46.79%-185.1%
2021-16.41%-137.5%
202043.80%+60.1%
201927.36%-69.3%
201889.15%-